Live tape
Top 8, mentions 7d15,466GOOGL6,803 mentions▲ +0.02MSFT1,818 mentions▲ +0.04AMZN1,541 mentions▲ +0.04META1,238 mentions▲ +0.03SPCX1,138 mentions▲ +0.06TSLA1,014 mentions▲ +0.06NVDA996 mentions▲ +0.06INTC918 mentions▲ +0.03

Equity · Healthcare

HURA

NASDAQ

TuHURA Biosciences, Inc./NV (HURA)

2.25 USD +2.27% vs prior close
TuHURA Biosciences, Inc. price graph

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for HURA to draw a line in its place.

Track this symbol on TradingView
Market cap
143.4M USD
Revenue, year to Dec 2025
0 USD
EPS, diluted, year to Dec 2025
−0.63 USD
52-week range
0.4396 USD – 3.24 USD
Avg volume
122.2K

as of Jul 17, 2026

Have TuHURA Biosciences, Inc./NV (HURA) insiders bought or sold shares recently?

HURA has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 28 May 2026.

Form 4

Have TuHURA Biosciences, Inc./NV (HURA) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
28 May 2026Bianco James A.Chief Executive OfficerGift150,000

Which funds hold TuHURA Biosciences, Inc./NV (HURA)?

4 of the 45 institutional funds we track reported a TuHURA Biosciences, Inc./NV position for the quarter ended 30 Jun 2026 — a combined 2.7M USD; the latest of those filings landed 02 Sep 2026.

Form 13F

Which funds hold TuHURA Biosciences, Inc./NV (HURA)?
FundPositionSharesValueShares q/q
Millennium ManagementNew position454,5351.1M USD
AQR Capital ManagementTrimmed424,600994K USD−30.1%
Citadel AdvisorsNew position232,319544K USD
Tudor Investment CorpNew position45,115106K USD

Have members of Congress traded TuHURA Biosciences, Inc./NV (HURA)?

The most recent congressional trade disclosed in TuHURA Biosciences, Inc./NV is a purchase by Laurel M. Lee (house, FL), dated 25 Nov 2024.

STOCK Act disclosures

Have members of Congress traded TuHURA Biosciences, Inc./NV (HURA)?
TradedMemberTypeAmountFiled after
25 Nov 2024Laurel M. Leehouse · Republican–FLPurchase1K USD–15K USD43 days
18 Oct 2024Laurel M. Leehouse · Republican–FLExchange100K USD–250K USD34 days

What has been filed or recorded for TuHURA Biosciences, Inc./NV (HURA)?

The filings we hold for TuHURA Biosciences, Inc./NV, newest first: 9 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 29 Sep 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for TuHURA Biosciences, Inc./NV (HURA)?
And
29 Sep 2026Fails to deliverShares failed to deliver20,138 shares42K USD notional · 0.032% of shares out
25 Sep 2026Fails to deliverShares failed to deliver60 shares126 USD notional · <0.001% of shares out
24 Sep 2026Fails to deliverShares failed to deliver1,882 shares4K USD notional · 0.003% of shares out
23 Sep 2026Fails to deliverShares failed to deliver113 shares241 USD notional · <0.001% of shares out
22 Sep 2026Fails to deliverShares failed to deliver10,338 shares23K USD notional · 0.016% of shares out
21 Sep 2026Fails to deliverShares failed to deliver4,443 shares9K USD notional · 0.007% of shares out
18 Sep 2026Fails to deliverShares failed to deliver7,653 shares16K USD notional · 0.012% of shares out
16 Sep 2026Fails to deliverShares failed to deliver4,324 shares9K USD notional · 0.007% of shares out
15 Sep 2026Fails to deliverShares failed to deliver5,305 shares11K USD notional · 0.008% of shares out
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −0.14 USD
30 Jun 2026FinancialsTotal assets31.7M USDat period end
30 Jun 2026FinancialsTotal equity18.5M USDat period end
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −0.13 USD
31 Dec 2025Annual reportFY 2025 reportedEPS −0.63 USD
31 Dec 2025FinancialsRevenue0 USDfiscal year
31 Dec 2025FinancialsNet income−30.1M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−0.63 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −0.14 USD
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −0.21 USD
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −0.15 USD
31 Dec 2024Annual reportFY 2024 reportedEPS −1.21 USD
30 Sep 2024Quarterly earningsQ3 2025 reportedEPS −0.54 USD

TuHURA Biosciences, Inc./NV (HURA): frequently asked questions

From live data
143.4M

What is TuHURA Biosciences, Inc./NV’s market cap?

TuHURA Biosciences, Inc./NV is worth 143.4M USD by market value as of 17 Jul 2026, which is the share price times the shares on issue from its SEC filings.

0

What is TuHURA Biosciences, Inc./NV’s revenue?

TuHURA Biosciences, Inc./NV reported revenue of 0 USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have TuHURA Biosciences, Inc./NV insiders bought or sold shares recently?

No TuHURA Biosciences, Inc./NV insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 28 May 2026 (SEC Form 4). See Insiders

4 of 45

Which funds own TuHURA Biosciences, Inc./NV?

4 of the 45 funds we track reported a TuHURA Biosciences, Inc./NV position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Millennium Management, AQR Capital Management and Citadel Advisors. See Funds

2 trades

Have members of Congress traded TuHURA Biosciences, Inc./NV?

Yes. 2 trades in TuHURA Biosciences, Inc./NV appear in the congressional disclosures we hold; the latest is a purchase by Laurel M. Lee (House, FL) dated 25 Nov 2024, filed 7 Jan 2025. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress

−0.14

When did TuHURA Biosciences, Inc./NV last report earnings?

TuHURA Biosciences, Inc./NV last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −0.14 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. House disclosuresU.S. House of Representatives financial disclosures
  6. SECSEC fails-to-deliver (CNS) data
  7. SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
  8. SEC EDGARreported earnings figures and scheduled report dates
  9. SEC EDGARValuation computed from SEC EDGAR filings